Vaasan Keskussairaala

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Kidney cancer1 trial
• Lung cancer1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Eisai Inc.1 trial
• Hoffmann-La Roche1 trial

Closed trials

• Completed

  A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer

  NCT05171777· Phase 2· Hoffmann-La Roche· Source

• Completed

  Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

  NCT03173560· Phase 2· Eisai Inc.· Source